PTGX Protagonist Therapeutics, Inc PHARMACEUTICAL PREPARATIONS Best Pharmaceutical Stocks 2026 →

Protagonist Therapeutics (PTGX) Stock: Buy, Sell, or Hold?

$136.26
+0.36 (+0.26%) ▲
5d: -2.84% 30d: -5.95% 90d: -10.36%
QUANTITATIVE VERDICT
HOLD
MODERATE Confidence (84%)
Quality Score
57/100
Position
SLIGHTLY LOW
30-Day Fair Range
$135.20 – $142.76
Position: SLIGHTLY LOW
Forward P/E & Valuation
226.8x STRETCHED
vs 83.6x historical avg
Wall Street Target
$182.36
+33.8% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$128.00 / $146.44
Trend: Uptrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: PTGX trades at premium valuation expecting 39.5% growth. Hold existing positions but don't chase. Wait for better entry.

Get Alerted When PTGX Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$0.30
Based on -42.2% avg growth
INTRINSIC VALUE TODAY
$0.18
Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: PTGX is currently trading at $136.26, which is considered slightly low relative to its 30-day fair value range of $135.20 to $142.76. From a valuation perspective, the stock is trading at a premium (Forward PE: 226.8) compared to its historical average (83.6). At these levels, the market is pricing in 39.5% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.

Technical Outlook: Technically, PTGX is in a uptrend. Immediate support is located at $128.00, while resistance sits at $146.44.

Market Sentiment: The stock scores a mixed 58/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $182.36 (+33.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position SLIGHTLY LOW
Historical Trading Range $135.20 - $142.76
Company Quality Score 57/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 83.5%

Trading Range & Key Levels

30-Day Trading Range $135.20 - $142.76
Current vs Trading Range SLIGHTLY LOW
Expected Move (7 Days) ±$7.21 (5.3%)
Support Level $128.00
Resistance Level $146.44
Current Trend Uptrend
Technical data as of Nov 10, 2026

Protect Your Profits

Holding PTGX? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

Quantitative Signal Breakdown

  • BULLISH: Price oversold vs 30-day range
  • BULLISH: Options cheap (IV 0th percentile)
  • NEUTRAL: Mixed technical signals (58/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 33.8% below Wall St target ($182.36)
  • NEUTRAL: PE elevated vs history but 39.5% growth expectation is conservative given 351% recent growth
  • NEUTRAL: Bottoming setup forming (58/100) — watch for confirmation

Fundamental Context

Forward P/E (Next Year Est.) 226.84
Wall Street Target $182.36 (+33.8%)
Revenue Growth (YoY) 5723.6%
Earnings Growth (YoY) 351.3%
Profit Margin 62.0%
Valuation Premium vs History +39.5% premium
PE vs Historical 226.8 vs 83.6 STRETCHED
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +39.5% (market-implied from PE analysis)
1-Year Target $190.08 (+40%)
2-Year Target $265.17 (+95%)
3-Year Target $369.91 (+172%)
3-Yr Target (if PE normalizes) (PE: 227→84) PE COMPRESSION $136.33 (+0%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 226.8, Growth: -88.3%) $99.33 (+-27%)
Base: (SPY PE: 19.9, Growth: -88.3%) $8.70 (-94%)
Bear: (PE: 16.9, Growth: -88.3%) $7.39 (-95%)
📈 Valuation based on Current Earnings
Trailing PE: 28.73 | Current EPS (TTM): $4.73
Bull Case $74.74 (-45%)
Analyst growth -50.0%, PE expands to 31.6
Base Case $67.95 (-50%)
Market implied -50.0%, PE stable at 28.7
Bear Case $92.41 (-32%)
Severe decline -20.0%, PE contracts to 24.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share PTGX Analysis

Share this live PTGX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (PTGX)

Bullish 1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Aug 17, 2026
Daily AI digest
AI Retail Discussion Summary: A bullish StockTwits user reported a 6.5% gain in $PTGX, expressing optimism for the upcoming week and urging investors to set alerts.
Key Retail Themes: Gain in $PTGX stock Positive outlook for the upcoming week
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 8:34 AM ET
Data refreshes hourly during market hours. Next update: 9:34 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for PTGX.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
RVMD
Revolution Medicines Inc
STRONG BUY
25 analysts
$261 52 HOLD
IONS
Ionis Pharmaceuticals Inc
STRONG BUY
25 analysts
$84 45 HOLD
ACLX
Arcellx Inc
STRONG BUY
18 analysts
$113 50 HOLD
VKTX
Viking Therapeutics Inc
STRONG BUY
21 analysts
$95 42 HOLD
GPCR
Structure Therapeutics I…
STRONG BUY
16 analysts
$107 49 HOLD

Advanced PTGX Option Strategies

Professional options setups generated by AI based on today's PTGX price and gamma walls.

Iron Condor Bull Call Bear Put Collar

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive PTGX Research Pages
PTGX Technical Chart PTGX Price Prediction PTGX Intrinsic Value DCF PTGX Earnings Date PTGX Investment Advisor PTGX Fair Price Analyzer PTGX Options Chain PTGX Options Advisor PTGX Options Analysis PTGX Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals